Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2348 entries
Sorted by: Best Match Show Resources per page
American Federation for Clinical Research and the Health Manpower Bill.

Clinical research

Challoner DR.
PMID: 800754
Clin Res. 1976 Apr;24(3):128-9.

No abstract available.

Cite
Challoner DR. American Federation for Clinical Research and the Health Manpower Bill. Clin Res. 1976;24(3):128-9
Challoner, D. R. (1976). American Federation for Clinical Research and the Health Manpower Bill. Clinical research, 24(3), 128-9.
Challoner, D R. "American Federation for Clinical Research and the Health Manpower Bill." Clinical research vol. 24,3 (1976): 128-9.
Challoner DR. American Federation for Clinical Research and the Health Manpower Bill. Clin Res. 1976 Apr;24(3):128-9. PMID: 800754.
Copy Download .nbib Format: NLM
Fumes from the spleen.

Paediatric and perinatal epidemiology

[No authors listed]
PMID: 2587404
Paediatr Perinat Epidemiol. 1989 Oct;3(4):353-5.

No abstract available.

Cite
Fumes from the spleen. Paediatr Perinat Epidemiol. 1989;3(4):353-5
(1989). Fumes from the spleen. Paediatric and perinatal epidemiology, 3(4), 353-5.
"Fumes from the spleen." Paediatric and perinatal epidemiology vol. 3,4 (1989): 353-5.
Fumes from the spleen. Paediatr Perinat Epidemiol. 1989 Oct;3(4):353-5. PMID: 2587404.
Copy Download .nbib Format: NLM
On clinically relevant differences and shifted null hypotheses.

Methods of information in medicine

Victor N.
PMID: 3670099
Methods Inf Med. 1987 Jul;26(3):109-16.

No abstract available.

Cite
Victor N. On clinically relevant differences and shifted null hypotheses. Methods Inf Med. 1987;26(3):109-16
Victor, N. (1987). On clinically relevant differences and shifted null hypotheses. Methods of information in medicine, 26(3), 109-16.
Victor, N. "On clinically relevant differences and shifted null hypotheses." Methods of information in medicine vol. 26,3 (1987): 109-16.
Victor N. On clinically relevant differences and shifted null hypotheses. Methods Inf Med. 1987 Jul;26(3):109-16. PMID: 3670099.
Copy Download .nbib Format: NLM
A simple method for the estimation of interaction bias in crossover studies.

Journal of clinical pharmacology

Cleophas TJ.
PMID: 2243151
J Clin Pharmacol. 1990 Nov;30(11):1036-40. doi: 10.1002/j.1552-4604.1990.tb03591.x.

The crossover trial is considered the most powerful means of determining the efficacy of new drugs. However this study design is frequently invalidated by treatment-by-period interaction. If, for example, the effect of the first treatment period carries on into...

Cite
Cleophas TJ. A simple method for the estimation of interaction bias in crossover studies. J Clin Pharmacol. 1990;30(11):1036-40doi: 10.1002/j.1552-4604.1990.tb03591.x.
Cleophas, T. J. (1990). A simple method for the estimation of interaction bias in crossover studies. Journal of clinical pharmacology, 30(11), 1036-40. https://doi.org/10.1002/j.1552-4604.1990.tb03591.x
Cleophas, T J. "A simple method for the estimation of interaction bias in crossover studies." Journal of clinical pharmacology vol. 30,11 (1990): 1036-40. doi: https://doi.org/10.1002/j.1552-4604.1990.tb03591.x
Cleophas TJ. A simple method for the estimation of interaction bias in crossover studies. J Clin Pharmacol. 1990 Nov;30(11):1036-40. doi: 10.1002/j.1552-4604.1990.tb03591.x. PMID: 2243151.
Copy Download .nbib Format: NLM
[Biomedical researches: for whom? for what? how?].

Annales medico-psychologiques

Brochier T, Pascalis JG, Theret L.
PMID: 2092598
Ann Med Psychol (Paris). 1990 Jun-Jul;148(6):598-9.

The law of December 20th 1988 provides for the protection of those people who lend themselves to clinical research, both patients and healthy subjects. The ex-expert clinicians are confronted with new drugs and protocols of experimentation enacted by industry....

Cite
Brochier T, Pascalis JG, Theret L. Recherches bio-médicales: pour qui? pour quoi? comment? [Biomedical researches: for whom? for what? how?]. Ann Med Psychol (Paris). 1990;148(6):598-9
Brochier, T., Pascalis, J. G., & Theret, L. (1990). Recherches bio-médicales: pour qui? pour quoi? comment? [Biomedical researches: for whom? for what? how?]. Annales medico-psychologiques, 148(6), 598-9.
Brochier, T, et al. "Recherches bio-médicales: pour qui? pour quoi? comment?" [Biomedical researches: for whom? for what? how?]. Annales medico-psychologiques vol. 148,6 (1990): 598-9.
Brochier T, Pascalis JG, Theret L. Recherches bio-médicales: pour qui? pour quoi? comment? [Biomedical researches: for whom? for what? how?]. Ann Med Psychol (Paris). 1990 Jun-Jul;148(6):598-9. French. PMID: 2092598.
Copy Download .nbib Format: NLM
[Good clinical practices. Point of view of the university hospital].

La Revue de medecine interne

Bader JP.
PMID: 3809775
Rev Med Interne. 1986 Nov;11-3.

For clinical investigators, usually on the staff of university hospitals, the setting up in France of a good clinical practices system will no doubt improve the quality of clinical trials in that country. It remains that the investigator's responsibility...

Cite
Bader JP. Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. Rev Med Interne. 1986;11-3
Bader, J. P. (1986). Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. La Revue de medecine interne, 11-3.
Bader, J P. "Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire." [Good clinical practices. Point of view of the university hospital]. La Revue de medecine interne vol. (1986): 11-3.
Bader JP. Les bonnes pratiques cliniques. Point de vue de l'hospitalo-universitaire. [Good clinical practices. Point of view of the university hospital]. Rev Med Interne. 1986 Nov;11-3. French. PMID: 3809775.
Copy Download .nbib Format: NLM
[How to read reports on clinical trials of drugs. II].

Casopis lekaru ceskych

Horácek J.
PMID: 3731219
Cas Lek Cesk. 1986 Jul 04;125(27):835-6.

No abstract available.

Cite
Horácek J. Jak císt zprávu o klinickém zkousení léku. II. [How to read reports on clinical trials of drugs. II]. Cas Lek Cesk. 1986;125(27):835-6
Horácek, J. (1986). Jak císt zprávu o klinickém zkousení léku. II. [How to read reports on clinical trials of drugs. II]. Casopis lekaru ceskych, 125(27), 835-6.
Horácek, J. "Jak císt zprávu o klinickém zkousení léku. II." [How to read reports on clinical trials of drugs. II]. Casopis lekaru ceskych vol. 125,27 (1986): 835-6.
Horácek J. Jak císt zprávu o klinickém zkousení léku. II. [How to read reports on clinical trials of drugs. II]. Cas Lek Cesk. 1986 Jul 04;125(27):835-6. Czech. PMID: 3731219.
Copy Download .nbib Format: NLM
Surrogate endpoints: a basis for a rational approach.

European journal of clinical pharmacology

Boissel JP, Collet JP, Moleur P, Haugh M.
PMID: 1425885
Eur J Clin Pharmacol. 1992;43(3):235-44. doi: 10.1007/BF02333016.

In clinical trials, the clinical endpoint is often replaced by an intermediate endpoint, known in some instances as a "surrogate" endpoint. The reasons for the substitution are often both practical and financial. At present, no theoretical basis or practical...

Cite
Boissel JP, Collet JP, Moleur P, et al. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol. 1992;43(3):235-44doi: 10.1007/BF02333016.
Boissel, J. P., Collet, J. P., Moleur, P., & Haugh, M. (1992). Surrogate endpoints: a basis for a rational approach. European journal of clinical pharmacology, 43(3), 235-44. https://doi.org/10.1007/BF02333016
Boissel, J P, et al. "Surrogate endpoints: a basis for a rational approach." European journal of clinical pharmacology vol. 43,3 (1992): 235-44. doi: https://doi.org/10.1007/BF02333016
Boissel JP, Collet JP, Moleur P, Haugh M. Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol. 1992;43(3):235-44. doi: 10.1007/BF02333016. PMID: 1425885.
Copy Download .nbib Format: NLM
[The pyramids of cardiology].

Giornale italiano di cardiologia

Masoni A.
PMID: 3732712
G Ital Cardiol. 1986 Mar;16(3):191-5.

No abstract available.

Cite
Masoni A. Le piramidi della cardiologia. [The pyramids of cardiology]. G Ital Cardiol. 1986;16(3):191-5
Masoni, A. (1986). Le piramidi della cardiologia. [The pyramids of cardiology]. Giornale italiano di cardiologia, 16(3), 191-5.
Masoni, A. "Le piramidi della cardiologia." [The pyramids of cardiology]. Giornale italiano di cardiologia vol. 16,3 (1986): 191-5.
Masoni A. Le piramidi della cardiologia. [The pyramids of cardiology]. G Ital Cardiol. 1986 Mar;16(3):191-5. Italian. PMID: 3732712.
Copy Download .nbib Format: NLM
Healthy volunteers, risk, and research.

Drug intelligence & clinical pharmacy

Powell JR.
PMID: 3769765
Drug Intell Clin Pharm. 1986 Oct;20(10):776-7. doi: 10.1177/106002808602001007.

No abstract available.

Cite
Powell JR. Healthy volunteers, risk, and research. Drug Intell Clin Pharm. 1986;20(10):776-7doi: 10.1177/106002808602001007.
Powell, J. R. (1986). Healthy volunteers, risk, and research. Drug intelligence & clinical pharmacy, 20(10), 776-7. https://doi.org/10.1177/106002808602001007
Powell, J R. "Healthy volunteers, risk, and research." Drug intelligence & clinical pharmacy vol. 20,10 (1986): 776-7. doi: https://doi.org/10.1177/106002808602001007
Powell JR. Healthy volunteers, risk, and research. Drug Intell Clin Pharm. 1986 Oct;20(10):776-7. doi: 10.1177/106002808602001007. PMID: 3769765.
Copy Download .nbib Format: NLM
[Type 1, 2 and 3 errors].

Nordisk medicin

Forrest M, Andersen B.
PMID: 3831940
Nord Med. 1985;100(10):272-4.

No abstract available.

Cite
Forrest M, Andersen B. Type 1, 2 og 3 fejl. [Type 1, 2 and 3 errors]. Nord Med. 1985;100(10):272-4
Forrest, M., & Andersen, B. (1985). Type 1, 2 og 3 fejl. [Type 1, 2 and 3 errors]. Nordisk medicin, 100(10), 272-4.
Forrest, M, and Andersen, B. "Type 1, 2 og 3 fejl." [Type 1, 2 and 3 errors]. Nordisk medicin vol. 100,10 (1985): 272-4.
Forrest M, Andersen B. Type 1, 2 og 3 fejl. [Type 1, 2 and 3 errors]. Nord Med. 1985;100(10):272-4. Danish. PMID: 3831940.
Copy Download .nbib Format: NLM
Loss of power from an optimistic alternative hypothesis.

Statistics in medicine

Blumenson LE.
PMID: 3368672
Stat Med. 1988 Apr;7(4):457-66. doi: 10.1002/sim.4780070402.

In the planning of a clinical trial to compare the proportion of responses to two treatments one determines the sample size to yield the desired power of achieving a significant difference at a pre-selected type I error under the...

Cite
Blumenson LE. Loss of power from an optimistic alternative hypothesis. Stat Med. 1988;7(4):457-66doi: 10.1002/sim.4780070402.
Blumenson, L. E. (1988). Loss of power from an optimistic alternative hypothesis. Statistics in medicine, 7(4), 457-66. https://doi.org/10.1002/sim.4780070402
Blumenson, L E. "Loss of power from an optimistic alternative hypothesis." Statistics in medicine vol. 7,4 (1988): 457-66. doi: https://doi.org/10.1002/sim.4780070402
Blumenson LE. Loss of power from an optimistic alternative hypothesis. Stat Med. 1988 Apr;7(4):457-66. doi: 10.1002/sim.4780070402. PMID: 3368672.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2348 entries